All lobbying filings
CASSIDY & ASSOCIATES, INC.
CASSIDY & ASSOCIATES, INC. filed a Q3 report for SEQIRUS USA INC on October 15, 2026, reporting $50,000 in lobbying income.
Lobbying for SEQIRUS USA INC · Pharmaceutical Manufacturing
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 15, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New Jersey
Government bodies contacted
2
Lobbying activity
2
FY27 National Defense Authorization Act (S.4784, H.R. 8800)
FY27 National Defense Authorization (H.R. 8800, S.4784) and FY27 Appropriations